CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	May 31, 2024	May 31, 2023
Cash flows from operating activities
Net loss from continuing operations	$ (2,398,921)	$ (1,548,784)
Net loss from discontinued operations	(11,797)	(259,320)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation	9,213	11,115
Stock based compensation expense	351,958	134,655
Impairment of fixed assets	683,950	(0)
Changes in operating assets and liabilities:
Deferred research and development costs	(10,184)	43,236
Prepaid expenses and other assets	149,957	(102,596)
Accounts payable and accrued expenses	22,398	67,809
Related party payable	53,864	69,812
Net cash used in operating activities	(1,149,562)	(1,584,073)
Cash flows from investing activities
Purchase of short-term investments	(4,000,000)	(6,000,000)
Redemption of short-term investments	5,500,000	0
Capital expenditures	(1,949)	0
Net cash provided by (used in) investing activities	1,498,051	(6,000,000)
Effect of exchange rate changes on cash and cash equivalents	(1)	(505)
Net increase (decrease) in cash and cash equivalents	348,488	(7,584,578)
Cash and cash equivalents at beginning of period	492,610	8,077,849
Cash and cash equivalents at end of period	$ 841,098	$ 493,271